- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01564771
Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)
30 november 2018 uppdaterad av: Pfizer
Serotype distribution and estimation of antimicrobial resistance in S. pneumoniae isolates and anticipated PCV7 and PCV13 coverage is difficult in Greece, because invasive isolates collected each year are limited and depict a certain proportion of patients who have easy access to tertiary care or have underlying medical reasons which necessitate inpatient care.
It is also probable that the real burden of pneumococcal disease is not well estimated especially among adults.
New additions in the laboratory setting such as the pneumococcal urine antigen assay (Binax NOW®) and the Urinary Antigen Diagnostic Assay (Luminex) for the detection of 13 serotype specific polysaccharides in human urine developed by Pfizer might be helpful in identifying more pneumococcal infections compared to the previous years.
This NIS is based on the unmet scientific need to describe the serotype distribution and the resistance profile of isolates from X-Ray confirmed CAP in the present circumstances.
Studieöversikt
Detaljerad beskrivning
For each surveillance period lasting for 12 months all adults presenting in the selected clinics with symptoms and signs suggestive of pneumonia (candidate cases) will be asked to participate in the study
Studietyp
Observationell
Inskrivning (Faktisk)
293
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Alexandroupoli, Grekland, 68100
- General University Hospital of Alexandroupoli
-
Athens, Grekland, 11527
- General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
-
Athens, Grekland, 11527
- General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
-
Athens, Grekland, 11527
- General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
-
Athens, Grekland, 11527
- General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
-
Athens, Grekland, 11527
- General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
-
Athens, Grekland, 11527
- General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
-
Athens, Grekland, 11527
- General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
-
Athens, Grekland, 15123
- Diagnostic Therapeutic Center of Athens Ygeia
-
Athens, Grekland, 15126
- General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
-
Athens, Grekland, 15126
- General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
-
Athens, Grekland, 15126
- General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
-
Athens, Grekland, 15127
- General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
-
Athens, Grekland, 15127
- General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
-
Athens, Grekland, 15227
- Sotiria Hospital, Intensive Care Unit
-
Athnens, Grekland
- General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
-
Kavala, Grekland, 65201
- General Hospital of Kavala/ A Pneumonological Clinic
-
Kavala, Grekland, 65201
- General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
-
Larissa, Grekland, 41 110
- University General Hospial of Larissa, Pneumonology Department
-
-
Attiki
-
Athens, Attiki, Grekland
- General Hospital of Athens "Evangelismos" / Pneumonology Department
-
-
Evros
-
Alexandroupoli, Evros, Grekland, 68100
- University Hospital of Alexandroupolis
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Testmetod
Icke-sannolikhetsprov
Studera befolkning
Adults ≥18 years of age with chest X-ray confirmed CAP
Beskrivning
Inclusion Criteria:
- Patients who agreed to participate in the study and agreed to sign an ICD.
- Patients had to be ≥18 years of age (adults)
- Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
- Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
- Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)
Exclusion Criteria:
- Patients who did not sign an ICD.
- Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
- Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
- Patients who did not have a chest X-ray performed
- Patients who did not have the Binax NOW® assay performed
- Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Endast fall
- Tidsperspektiv: Blivande
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
|
This Is A Non Interventional Study
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
Tidsram: One year
|
One year
|
|
calendar year.
Tidsram: One year
|
One year
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
Tidsram: One year
|
One year
|
|
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
Tidsram: One year
|
One year
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 januari 2011
Primärt slutförande (Faktisk)
1 april 2013
Avslutad studie (Faktisk)
1 april 2013
Studieregistreringsdatum
Först inskickad
26 mars 2012
Först inskickad som uppfyllde QC-kriterierna
27 mars 2012
Första postat (Uppskatta)
28 mars 2012
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
3 december 2018
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
30 november 2018
Senast verifierad
1 november 2018
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- B1851065
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
produkt tillverkad i och exporterad från U.S.A.
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .